EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Primary neuroendocrine tumors of the breast according to the WHO 2019 classification; real life experiences of rare tumor types of the breast

Seda Sali iD, Mursel Sali iD, Burcu Caner iD, Birol Ocak iD, Eyup Coban iD, Alper Coskun iD, Mine Ozsen iD, Sibel Oyucu Orhan iD, Ahmet Bilgehan Sahin iD, Adem Deligonul iD, Erdem Cubukcu iD, Sahsine Tolunay iD und 1 weitere

The Oncologist · 2025

DOI: 10.1093/oncolo/oyaf171 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Oncologist, 2025. Verfasst von Seda Sali und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, Bursa City Hospital, 16110 Nilufer, Turkey. Hauptthemen laut MEDLINE: Breast Neoplasms, Neuroendocrine Tumors. Die Arbeit nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Neuroendocrine neoplasms (NEN) originate in many body parts, with 70% reported from the gastrointestinal system, 25% from the lungs. NENs of the breast account for < 1% of all NENs. The primary breast NEN nomenclature was changed in the most recent World Health Organization classification in 2019. Since the pathological classification has changed several times, there are no definitive data on treatment management.

Methods

In this study, patients followed up in our clinic were pathologically reevaluated according to the latest classification.

Results

The clinical characteristics, treatments, recurrence, and survival status of 36 patients with early stage primary breast NEN were examined. A statistically significant difference was determined in respect of overall survival (OS) for the Eastern Cooperative Oncology Group Performance Score (ECOG PS), type of surgery, age ≥ 70 years, PR positivity, and tumor size. A low ECOG PS, younger age, breast-conserving surgery (BCS), and small tumor diameter were associated with better survival. A low ECOG PS, early stage, BCS, and fewer than 4 malignant lymph nodes were associated with better disease-free survival. All the patients in this study were at an early stage and were treated for typical breast cancer, although some patients diagnosed with neuroendocrine carcinoma (NEC) received cisplatin and etoposide treatment.

Conclusions

In our study, the prognosis of breast NEN patients was better than the literature data. Maybe the prognosis of patients evaluated as breast NEN according to the new classification is better than the older classification groups.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsNeuroendocrine TumorsHumansFemaleAgedMiddle AgedWorld Health OrganizationAdultPrognosisAged, 80 and over

Stichwörter der Autor:innen

breast cancerneuroendocrin tumorssurvivalsynaptophysin

Autor:innen und Institutionen

  • Department of Medical Oncology, Bursa City Hospital, 16110 Nilufer, Turkey.
  • Department of Medical Oncology, School of Medicine, Bursa Uludag University, 16059 Gorukle, Turkey.
  • Department of Medical Oncology, Aydin Ataturk State Hospital, 09100 Aydin, Turkey.
  • Department of Medical Oncology, Bursa Yuksek Ihtisas Training and Research Hospital, 16310 Yildirim, Turkey.
  • Department of Pathology, School of Medicine, Bursa Uludag University, 16059 Gorukle, Turkey.

ORCID-Profile: Seda Sali, Mursel Sali, Burcu Caner, Birol Ocak, Eyup Coban, Alper Coskun, Mine Ozsen, Sibel Oyucu Orhan, Ahmet Bilgehan Sahin, Adem Deligonul, Erdem Cubukcu, Sahsine Tolunay, Turkkan Evrensel

Zitieren

APA

Sali, S., Sali, M., Caner, B., Ocak, B., Coban, E., Coskun, A., Ozsen, M., Oyucu Orhan, S., Sahin, A. B., Deligonul, A., Cubukcu, E., Tolunay, S., & Evrensel, T. (2025). Primary neuroendocrine tumors of the breast according to the WHO 2019 classification; real life experiences of rare tumor types of the breast. The Oncologist. https://doi.org/10.1093/oncolo/oyaf171

Vancouver

Sali S, Sali M, Caner B, Ocak B, Coban E, Coskun A, et al. Primary neuroendocrine tumors of the breast according to the WHO 2019 classification; real life experiences of rare tumor types of the breast. The Oncologist. 2025. doi:10.1093/oncolo/oyaf171

BibTeX
@article{Sali2025,
  author = {Sali, Seda and Sali, Mursel and Caner, Burcu and Ocak, Birol and Coban, Eyup and Coskun, Alper and Ozsen, Mine and Oyucu Orhan, Sibel and Sahin, Ahmet Bilgehan and Deligonul, Adem and Cubukcu, Erdem and Tolunay, Sahsine and Evrensel, Turkkan},
  title = {Primary neuroendocrine tumors of the breast according to the WHO 2019 classification; real life experiences of rare tumor types of the breast},
  journal = {The Oncologist},
  year = {2025},
  doi = {10.1093/oncolo/oyaf171}
}
Kostenlos starten →